Trexquant Investment’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.7M Buy
594,850
+295,446
+99% +$9.69M 0.12% 202
2025
Q4
$11.2M Buy
299,404
+27,433
+10% +$902K 0.1% 274
2025
Q3
$7.5M Buy
271,971
+167,533
+160% +$5.77M 0.08% 395
2025
Q2
$3.3M Sell
104,438
-9,290
-8% -$299K 0.04% 701
2025
Q1
$3.77M Sell
113,728
-61,846
-35% -$2.22M 0.04% 617
2024
Q4
$6.04M Buy
+175,574
New +$6.03M 0.07% 454
2023
Q3
Sell
-57,468
Closed -$2.02M 1611
2023
Q2
$2.02M Buy
57,468
+42,259
+278% +$1.46M 0.05% 488
2023
Q1
$497K Sell
15,209
-18,052
-54% -$822K 0.01% 1005
2022
Q4
$1.83M Buy
33,261
+24,047
+261% +$1.32M 0.05% 432
2022
Q3
$408K Sell
9,214
-6,344
-41% -$309K 0.01% 893
2022
Q2
$759K Buy
15,558
+530
+4% +$23.9K 0.03% 633
2022
Q1
$731K Buy
15,028
+354
+2% +$14.4K 0.03% 606
2021
Q4
$626K Sell
14,674
-5,786
-28% -$231K 0.04% 551
2021
Q3
$784K Buy
20,460
+9,272
+83% +$299K 0.06% 385
2021
Q2
$316K Buy
+11,188
New +$336K 0.03% 687

Other funds holding HRMY